Medclair AB (NGM:MCLR)

Market Cap	265.78M +66.1%
Revenue (ttm)	58.80M +63.6%
Net Income	4.46M
EPS	0.05
Shares Out	91.65M
PE Ratio	52.87
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	381,750
Open	n/a
Previous Close	2.800
Day's Range	n/a
52-Week Range	1.855 - 3.350
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Medclair AB

Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O) in Sweden. It offers mobile destruction unit, a mobile unit that enables the destruction of nitrous oxide; central destruction unit, an ideal solution for situations where Nitrous Oxide (N2O) is used simultaneously in multiple treatment rooms; Recycling Decomposition Unit, an intelligent solution that effectively collects Nitrous Oxide (N2O) from discarded N2O canisters and decomposes it within a self-supporting sy...

• Industry: Crude Petroleum and Natural Gas
• Founded: 2005
• Employees: 15
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: MCLR

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 10, 2026

Data Sources Report a data error